Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
Running, not enrolling · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Alzheimers Disease, Dementia, Alzheimers Disease, Familial
In brief
To assess the safety, tolerability, biomarker, cognitive, and clinical efficacy of investigational products in participants with an Alzheimer's disease-causing mutation by determining if treatment with the study drug improves disease-related biomarkers and slows the rate of progression of cognitive or clinical impairment.
Key facts
- Study ID
- NCT05269394
- Run by
- Washington University School of Medicine
- People needed
- 197
- Starts
- 2021-12-22
- Expected to finish
- 2028-07-01
- Last updated by the study team
- 2026-07-27
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama in Birmingham — Birmingham, Alabama, United States
- University of California San Diego Medical Center — La Jolla, California, United States
- USC Keck School of Medicine — Los Angeles, California, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- Emory University — Atlanta, Georgia, United States
- Advocate Lutheran General Hospital — Park Ridge, Illinois, United States
- Indiana University School of Medicine — Indianapolis, Indiana, United States
- Washington University in St. Louis — St Louis, Missouri, United States
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
- Butler Hospital — Providence, Rhode Island, United States
- Kerwin Research Center, — Dallas, Texas, United States
- University of Washington — Seattle, Washington, United States
- Instituto de Investigaciones Neurologicas Raul Carrea, FLENI — Ciudad Autonoma de Buenos Aire, Argentina
- Neuroscience Research Australia — Randwick, New South Wales, Australia
- Alzheimer's Research Australia — Melbourne, Victoria, Australia
- Hospital das Clínicas da Faculdade de Medicina da USP — São Paulo, Brazil
- Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada
- McGill Center for Studies in Aging — Verdun, Quebec, Canada
- CHU de Quebec - Hôpital de l' Enfant Jésus — Québec, Canada
- Grupo de Neurociencias Sede de la Universidad de Antioquia — Medellín, Colombia
- CHU de Toulouse - Hôpital Purpan — Toulouse, Haute Garonne, France
- Hopital Roger Salengro - CHU Lille — Lille, Nord, France
- Groupe Hospitalier Pitie-Salpetriere — Paris, Paris, France
- Hopital Neurologique Pierre Wertheimer — Bron, Rhone, France
- CHU de Rouen - Hôpital Charles Nicolle — Rouen, Seine Maritime, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.